As of 4:02pm ET
| +0.08 / +4.21%|
The 3 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 6.00, with a high estimate of 7.50 and a low estimate of 2.50. The median estimate represents a +203.03% increase from the last price of 1.98.
The current consensus among 3 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.